Issue |
J Oral Med Oral Surg
Volume 26, Number 1, 2020
|
|
---|---|---|
Article Number | 6 | |
Number of page(s) | 8 | |
Section | Revue de la littérature / Literature review | |
DOI | https://doi.org/10.1051/mbcb/2019037 | |
Published online | 27 January 2020 |
Literature Review
Analysis of leptin concentrations in oral fluids (saliva and crevicular gingival fluid) and blood in patients with chronic periodontal disease: systematic review of literature
1
CHU Clermont-Ferrand, Service d'Odontologie, 63003 Clermont-Ferrand, France
2
CHU Clermont-Ferrand, Service de Stomatologie, Chirurgie maxillo-faciale et chirurgie plastique de la face, 63003 Clermont-Ferrand, France
3
Université Clermont Auvergne, Neuro-Dol, BP 10448, 63000, Clermont-Ferrand & Inserm U1107, 63001 Clermont-Ferrand, France
* Correspondence: laurent.devoize@udamail.fr
Received:
15
July
2019
Accepted:
14
November
2019
Objective: The objective of this systematic analysis was to perform a qualitative and quantitative synthesis of the literature concerning salivary and serum leptin variations in patients with chronic periodontitis (CP) compared with healthy subjects. Saliva leptin concentration analysis could be a relevant and non-invasive biological test for the evaluation of periodontal disease in both medical and clinical trials, beyond the clinical and radiographic elements. Material and Method: Querying the PubMed and Web of Science databases identified articles that met our inclusion criteria. Quantitative analysis of the literature data was performed with the Review Manager 5.3 software. Results: The qualitative analysis included 14 articles and showed a decrease of salivary leptin (5 studies out of 5) and an increase of serum leptin (11 of 12 studies) in patients with CP compared to unaffected subjects of CP. Quantitative analysis was performed on 4 trials. For salivary leptin, we confirmed a decrease in its level in patients with CP with a standardized mean difference (SMD) of −2.27, 95% CI [−2.68, −1.86]. The difference was highly significant but we detected a very important heterogeneity in this dataset (I2 = 94%). For serum leptin, we also confirmed an increase in its rate in patients with CP with an SMD of 2.18, 95% CI [1.75, 2.61]. The difference was highly significant but the heterogeneity measured in this dataset was also too high (I2 = 95%). Conclusion: The current level of evidence was insufficient to assert an increase in serum leptin and a decrease in salivary leptin in CP patients compared to healthy controls due to a great heterogeneity of the values measured in the studies.
Key words: leptin / periodontal disease / saliva / crevicular fluid / serum
© The authors, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.